前列腺癌核医学诊断市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00009519
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 180
Buy Now

前列腺癌核医学诊断市场预计将从 2022 年的 7.2012 亿美元增长到 2028 年的 13.1566 亿美元。预计 2022 年至 2028 年复合年增长率为 10.6%。

癌症影响男性的前列腺。前列腺癌是男性继皮肤癌之后的常见癌症。导致前列腺癌发生的一些常见决定因素是家族史、老年和种族。核医学是需要放射性材料的成像。它是识别和治疗前列腺癌的一种有用方法,可以帮助放射科医生得出癌症分期。

前列腺癌核医学诊断市场按类型、PET 产品、最终用户和地理位置进行分析。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美和非洲中美洲。前列腺癌核医学诊断市场报告提供了对市场的见解和深入分析,强调了市场趋势、市场动态以及全球领先市场参与者的竞争分析等参数。   

战略洞察

前列腺癌核医学诊断市场的利润丰厚的区域

市场洞察

对前列腺癌早期精确诊断的需求激增,推动前列腺癌核医学诊断市场

PSA水平的上升会增加前列腺癌的风险。血液中的 PSA 水平以纳克每毫升 (ng/mL) 为单位。没有明确的分界点可以确定男性是否患有前列腺癌。在评估男性是否需要进一步检测时,许多医生选择 4 ng/mL 或更高的 PSA 临界值,而其他医生可能主张从较低水平开始,例如 2.5 或 3。因此,检测男性血液中的 PSA 水平可以检测出早期前列腺癌。

直肠指检 (DRE) 是检测前列腺癌的另一种方法。在检查过程中,医生使用戴手套、润滑的手指来触摸前列腺。使用经过充分验证的生物标志物进行定期筛查可以更快地检测局部疾病。此外,区分低级别和高级别疾病对于避免不必要的活检、严重疾病治疗不足和惰性疾病过度治疗至关重要。

以下是一些推出新产品开发和产品批准的公司示例:

  • 2022 年 4 月,Telix 宣布其前列腺癌显像剂 Illuccix(用于制备镓 Ga 68 gozetotide 的试剂盒)也称为68Ga-PSMA-11注射液,将在美国上市。
  • 2022年3月,诺华宣布FDA批准Pluvicto(镥Lu 177 vipivotide tetraxetan)(原名177Lu-PSMA-617) )用于治疗已扩散至身体其他部位(转移性)的前列腺特异性膜抗原阳性转移性去势抵抗性前列腺癌(PSMA 阳性 mCRPC)成年患者。
  • 2022 年 3 月,FDA 批准了一种补充诊断成像剂 Locametz,在用镓 68 进行放射性标记后可识别 PSMA 阳性病变。放射性标记后,该显像剂可用于通过正电子发射断层扫描来识别成年 mCRPC 患者的 PSMA 阳性病变。

市场参与者的此类产品开发正在推动前列腺癌核医学诊断市场。

类型洞察

根据类型,全球前列腺癌核医学诊断市场分为 SPECT 和 PET。 2021 年,PET 细分市场占据最大市场份额。此外,预计该细分市场在预测期内将实现最高的复合年增长率。 PET 作为诊断工具的采用率显着增加,因为它比其他诊断技术具有更高的准确性。诊断的准确性直接影响决策和治疗监测过程。对这些诊断程序的需求不断增长预计将推动预测期内前列腺癌核医学诊断市场的增长。

前列腺癌核医学诊断市场,由类型 – 2022年和2028年

服务洞察

基于PET产品,全球前列腺癌核医学诊断市场分为F-18、C-11和Ga68- PSMA。 F-18 细分市场可能会在 2022 年占据最大的市场份额。然而,Ga68-PSMA 细分市场预计在预测期内将实现最高的复合年增长率。 Ga68-PSMA 是一种非侵入性诊断方法,利用增强的前列腺特异性膜抗原 (PSMA) 表达对前列腺癌进行成像。 PSMA 是一种遍布前列腺的跨膜蛋白。 PSMA 表达在多种癌症中上调,但前列腺癌的水平最高。此外,PSMA 表达对疾病结果具有预测价值。 PET 产生半定量图像,通过测量 Ga68-PSMA 的三维分布,能够非侵入性地测量 PSMA 表达。

伙伴关系和协作是高度采用的策略由全球前列腺癌核医学诊断市场参与者提供。下面列出了最近的一些关键市场发展:

  • 2022 年 4 月,Telix 宣布与 Avanço 和 THP 合作,为葡萄牙和奥地利经销 Telix 的前列腺癌研究成像产品,捷克共和国和斯洛伐克共和国市场。
  • 2022 年 8 月,Telix 发布了 ProstACT 计划下两项辅助研究的详细信息,其中包括与 GenesisCare 合作的一项 II 期研究。
  • 2021 年 2 月,Theragnostics 宣布与埃森大学医院达成一项研究协议,研究 THG-008 在多种癌症中的 PET 成像,因为放射性标记的 PARP 抑制剂有可能提高癌症患者的生存率。

COVID-19 大流行情况为前列腺癌核医学诊断市场的参与者展示了一些有利的前景。北美地区的很多人都受到了 COVID 19 的影响。美国是北美地区受影响最严重的国家。这种感染严重影响了该国的老年人口,引起各种并发症并导致大量人口死亡。例如,截至 2022 年 5 月 16 日,美国报告新冠肺炎病例 84,230,829 例,死亡 1,026,670 人。此外,慢性伤口或不愈合伤口多见于老年人,且需要较长时间才能愈合。因此,需要进行前列腺癌核医学诊断和适当护理,以预防慢性感染病例和健康状况。

此外,由于 COVID-19 的爆发,各种医院正在努力治疗受影响的人。 COVID-19 疫情导致癌症筛查大幅下降。然而,疫情导致美国筛查全面缺失。据认为,与 COVID-19 相关的癌症筛查延误导致了与该流行病直接相关的额外死亡人数。前列腺活检和 PC 诊断率在 COVID-19 大流行期间下降,尤其是在疫情高峰期间。

此外,在大流行之前,欧洲(主要是英国)的影像服务,长期投资不足,缺乏成像采集和报告能力。例如,这与劳动力和设备严重短缺有关。但随着新的 IPC 措施的实施,特别是所有医疗机构中 200 万的社交距离,在撰写本文时,这些短缺已满足 CT 能力的要求,约为新冠疫情前水平的 40-70%。另外,MRI稍好一点,占80%。此外,影像服务部门正在努力通过恢复能力和恢复患者信心来重新获得动力。很明显,只有通过大量投资来解决放射科医生、放射技师和成像设备长期资金不足的问题,才能实现根本性的改变。

前列腺癌核医学诊断–市场细分

根据类型、PET 产品、最终用户和地理位置对全球前列腺癌核医学诊断市场进行分析。从类型来看,市场分为 PET 和 SPECT。根据PET产品,市场分为F-18、C-11和Ga68-PSMA。根据最终用户,市场分为医院、诊所等。从地域上看,前列腺癌核医学诊断市场分为北美、欧洲、亚太地区、中东和非洲。非洲、南美和非洲中美洲。

公司简介

  • Blue Earth Diagnostics Limited    
  • ImaginAb     
  • 锔       
  • Jubilant Radiopharma        
  • NCM-USA LLC         
  • ABX 高级生化化合物有限公司   
  • 泰利克斯制药有限公司           
  • 诺华公司          
  • 治疗学         
  • Lantheus Medical Imaging, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the prostate cancer nuclear medicine diagnostics market?

Prostate cancer affects the prostate glands in males. Prostate cancer is common cancer following skin cancer in males. Some common determinants responsible for prostate cancer are family history, old age, and race. Nuclear medicine is imaging that needs radioactive materials. It is a helpful method to identify and treat prostate cancer and helps radiologists conclude the stage of cancer. Prostate cancer (PCa) is the fourth most common cancer across the US in terms of occurrence.

What are the driving factors for the prostate cancer nuclear medicine diagnostics market across the country?

Factors such as the rising prevalence of prostate cancer and surging demand for early and precise diagnosis of prostate cancer.

What are the restraining factors for the prostate cancer nuclear medicine diagnostics market across the country?

The high cost related to the prostate cancer diagnostics and treatment is expected to restrict the market growth during the forecast period

Who are the major players in market the prostate cancer nuclear medicine diagnostics market?

The prostate cancer nuclear medicine diagnostics market majorly consists of the players such as Blue Earth Diagnostics Limited, ImaginAB, Curium, Jubilant Radiopharma, NCM-USA LLC, ABX Advanced Biochemical Compounds GmbH, Telix Pharmaceuticals Ltd., Novartis AG, Theragonostics, and Lantheus Medical Imaging Inc.

Which segment is dominating the prostate cancer nuclear medicine diagnostics market?

The global prostate cancer nuclear medicine diagnostics market based on type, is segmented into SPECT and PET. In 2021, PET segment held largest market share and the segment is estimated to grow at the fastest CAGR of 10.8% during the forecast period.

Which region is dominating the prostate cancer nuclear medicine diagnostics market?

The global prostate cancer nuclear medicine diagnostics market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2021, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR of 11.2% during the forecast period

The List of Companies - Prostate Cancer Nuclear Medicine Diagnostics Market

  1. Blue Earth Diagnostics Limited
  2. ImaginAB
  3. Curium
  4. Jubilant Radiopharma
  5. NCM-USA LLC
  6. ABX Advanced Biochemical Compounds GmbH
  7. Telix Pharmaceuticals Ltd.
  8. Novartis AG
  9. Theragonostics
  10. Lantheus Medical Imaging Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports